Skip to main content

Table 2 OHSS-related clinical and laboratory data

From: Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study

 

Control

Study

P value

Number of retrieved oocytes

20.4 ± 1.6

21.1 ± 1.7

>0.05

Number of follicles (diameter of >16 mm)

17.1 ± 2.6

18 ± 3.2

>0.05

Serum E2 concentrations (pg/ml)

5004 ± 792

4761 ± 940

>0.05

Ovarian maximum diameter (mm)

10.4 ± 5.8

9.4 ± 4.5

>0.05

Frequency of associated symptoms

Distension

19 (79.2%)

20 (83.3%)

>0.05

Nausea

19 (79.2%)

18 (75%)

>0.05

Vomiting

10 (41.7%)

12 (50%)

>0.05

Laboratory findings

Ht value (%)

Strata

<40

14 (58.3%)

17 (70.8%)

>0.05

40–45

6 (25%)

6 (25%)

>45

4 (16.7%)

1 (4.2%)

Mean value

39.8 ± 4.2

42.2 ± 5.2

>0.05

TLC (× 103 cells/ml)

Strata

<10

4 (16.7%)

12 (50%)

>0.05

10–15

14 (58.3%)

8 (33.3%)

>15

6 (25%)

4 (16.7%)

Mean count

11.6 ± 3.7

12.75 ± 3.1

>0.05

Ascites

US detected

Low

6 (25%)

8 (33.3%)

>0.05

Moderate

18 (75%)

16 (66.7%)

Marked (Clinically detected)

0

0

  1. Data are presented as mean ± SD & numbers; percentages are in parenthesis